Insmed, Inc. (INSM)
96.27
-2.94
(-2.96%)
USD |
NASDAQ |
Oct 16, 16:00
96.35
+0.08
(+0.08%)
After-Hours: 20:00
Insmed Net Income (TTM) : -875.31M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -875.31M |
| March 31, 2026 | -1.184B |
| December 31, 2025 | -1.277B |
| September 30, 2025 | -1.184B |
| June 30, 2025 | -1.034B |
| March 31, 2025 | -1.013B |
| December 31, 2024 | -913.77M |
| September 30, 2024 | -864.28M |
| June 30, 2024 | -802.69M |
| March 31, 2024 | -746.89M |
| December 31, 2023 | -749.57M |
| September 30, 2023 | -723.63M |
| June 30, 2023 | -695.84M |
| March 31, 2023 | -546.68M |
| December 31, 2022 | -481.53M |
| September 30, 2022 | -434.39M |
| June 30, 2022 | -415.96M |
| March 31, 2022 | -437.63M |
| December 31, 2021 | -434.65M |
| September 30, 2021 | -423.89M |
| June 30, 2021 | -374.83M |
| March 31, 2021 | -319.37M |
| December 31, 2020 | -294.09M |
| September 30, 2020 | -244.86M |
| June 30, 2020 | -241.89M |
| Date | Value |
|---|---|
| March 31, 2020 | -246.55M |
| December 31, 2019 | -254.34M |
| September 30, 2019 | -292.92M |
| June 30, 2019 | -319.98M |
| March 31, 2019 | -329.91M |
| December 31, 2018 | -324.28M |
| September 30, 2018 | -298.09M |
| June 30, 2018 | -255.52M |
| March 31, 2018 | -223.76M |
| December 31, 2017 | -192.65M |
| September 30, 2017 | -195.67M |
| June 30, 2017 | -188.25M |
| March 31, 2017 | -180.16M |
| December 31, 2016 | -176.27M |
| September 30, 2016 | -139.12M |
| June 30, 2016 | -132.32M |
| March 31, 2016 | -124.35M |
| December 31, 2015 | -118.18M |
| September 30, 2015 | -104.58M |
| June 30, 2015 | -97.61M |
| March 31, 2015 | -92.23M |
| December 31, 2014 | -79.16M |
| September 30, 2014 | -77.73M |
| June 30, 2014 | -71.06M |
| March 31, 2014 | -56.69M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Biogen, Inc. | 834.60M |
| Gilead Sciences, Inc. | -3.24B |
| United Therapeutics Corp. | 1.311B |
| Vertex Pharmaceuticals, Inc. | 4.405B |